Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker

连接器 结合 部分 化学 抗体-药物偶联物 生物化学 立体化学 单克隆抗体 生物 抗体 免疫学 计算机科学 数学 操作系统 数学分析
作者
Marco Zambra,Ivan Ranđelović,Francesco Talarico,Adina Borbély,Laura Svajda,József Tóvári,Gábor Mező,Lizeth Bodero,Sveva Colombo,Federico Arrigoni,Elettra Fasola,Silvia Gazzola,Umberto Piarulli
出处
期刊:Frontiers in Pharmacology [Frontiers Media]
卷期号:14: 1215694-1215694 被引量:13
标识
DOI:10.3389/fphar.2023.1215694
摘要

Antibody-Drug Conjugates (ADCs) and Small Molecule-Drug Conjugates (SMDCs) represent successful examples of targeted drug-delivery technologies for overcoming unwanted side effects of conventional chemotherapy in cancer treatment. In both strategies, a cytotoxic payload is connected to the tumor homing moiety through a linker that releases the drug inside or in proximity of the tumor cell, and that represents a key component for the final therapeutic effect of the conjugate. Here, we show that the replacement of the Val-Ala-p-aminobenzyloxycarbamate linker with the Gly-Pro-Leu-Gly-p-aminobenzyloxycarbamate (GPLG-PABC) sequence as enzymatically cleavable linker in the SMDC bearing the cyclo[DKP-isoDGR] αVβ3 integrin ligand as tumor homing moiety and the monomethyl auristatin E (MMAE) as cytotoxic payload led to a 4-fold more potent anti-tumoral effect of the final conjugate on different cancer cell lines. In addition, the synthesized conjugate resulted to be significantly more potent than the free MMAE when tested following the “kiss-and-run” protocol, and the relative potency were clearly consistent with the expression of the αVβ3 integrin receptor in the considered cancer cell lines. In vitro enzymatic cleavage tests showed that the GPLG-PABC linker is cleaved by lysosomal enzymes, and that the released drug is observable already after 15 min of incubation. Although additional data are needed to fully characterize the releasing capacity of GPLG-PABC linker, our findings are of therapeutic significance since we are introducing an alternative to other well-established enzymatically sensitive peptide sequences that might be used in the future for generating more efficient and less toxic drug delivery systems.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Wwww发布了新的文献求助30
刚刚
loy完成签到,获得积分10
刚刚
MOMHANG完成签到,获得积分10
刚刚
下雨天睡个懒觉完成签到,获得积分10
刚刚
鬼医完成签到,获得积分10
1秒前
无花果的应助被雨滴油纸伞采纳,获得10
1秒前
CH完成签到,获得积分10
1秒前
1秒前
lx完成签到,获得积分10
1秒前
多买一只表完成签到 ,获得积分10
1秒前
烂漫的乐松完成签到,获得积分10
2秒前
七十三度发布了新的文献求助10
2秒前
外号胡一八完成签到 ,获得积分10
2秒前
白水完成签到,获得积分10
3秒前
傲慢帝完成签到,获得积分10
3秒前
杜小鱼发布了新的文献求助10
3秒前
kekeke完成签到 ,获得积分10
3秒前
华仔的应助被荷序采纳,获得10
3秒前
3秒前
666发布了新的文献求助10
3秒前
3秒前
3秒前
yin完成签到,获得积分20
4秒前
5秒前
无极微光的应助被xxz采纳,获得20
5秒前
缥缈听白完成签到,获得积分10
5秒前
5秒前
yexushifeng完成签到,获得积分10
5秒前
YSK819完成签到,获得积分10
6秒前
等待香薇发布了新的文献求助10
6秒前
kiminonawa发布了新的文献求助10
6秒前
6秒前
6秒前
Hello的应助被ph0307采纳,获得10
6秒前
july7292发布了新的文献求助10
7秒前
凌慕发布了新的文献求助10
7秒前
7秒前
7秒前
Owen的应助被干净夜云采纳,获得10
8秒前
yan完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180531
求助须知:如何正确求助?哪些是违规求助? 9570507
关于积分的说明 21812974
捐赠科研通 7776619
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557539
邀请新用户注册赠送积分活动 2479185